|
|
||||||||
,*


* Department of Pharmacology, Aventis Pharma, Dagenham, Essex, United Kingdom; and
Department of Pharmacology, Aventis Pharma, Bridgewater, NJ 08807
We postulated that the seleno-organic compound ebselen
would attenuate neutrophil recruitment and activation after aerosolized
challenge with endotoxin (LPS) through its effect as an antioxidant and
inhibitor of gene activation. Rats were given ebselen (1100 mg/kg
i.p.) followed by aerosolized LPS exposure (0.3 mg/ml for 30 min).
Airway inflammatory indices were measured 4 h postchallenge.
Bronchoalveolar lavage (BAL) fluid cellularity and myeloperoxidase
activity were used as a measure of neutrophil recruitment and
activation. RT-PCR analysis was performed in lung tissue to assess gene
expression of TNF-
, cytokine-induced neutrophil chemoattractant-1
(CINC-1), macrophage-inflammatory protein-2 (MIP-2), ICAM-1, IL-10, and
inducible NO synthase. Protein levels in lung and BAL were also
determined by ELISA. Ebselen pretreatment inhibited neutrophil influx
and activation as assessed by BAL fluid cellularity and myeloperoxidase
activity in cell-free BAL and BAL cell homogenates. This protective
effect was accompanied by a significant reduction in lung and BAL fluid
TNF-
and IL-1
protein and/or mRNA levels. Ebselen pretreatment
also prevented lung ICAM-1 mRNA up-regulation in response to airway
challenge with LPS. This was not a global effect of ebselen on
LPS-induced gene expression, because the rise in lung and BAL CINC-1
and MIP-2 protein levels were unaffected as were lung mRNA expressions
for CINC-1, MIP-2, IL-10, and inducible NO synthase. These data suggest
that the anti-inflammatory properties of ebselen are achieved
through an inhibition of lung ICAM-1 expression possibly through an
inhibition of TNF-
and IL-1
, which are potent neutrophil
recruiting mediators and effective inducers of ICAM-1
expression.
This article has been cited by other articles:
![]() |
A. Nadeem, A. Masood, and N. Siddiqui Review: Oxidant--antioxidant imbalance in asthma: scientific evidence, epidemiological data and possible therapeutic options Therapeutic Advances in Respiratory Disease, August 1, 2008; 2(4): 215 - 235. [Abstract] [PDF] |
||||
![]() |
J. A Mitchell, M. J Paul-Clark, G. W Clarke, S. K McMaster, and N. Cartwright Critical role of toll-like receptors and nucleotide oligomerisation domain in the regulation of health and disease J. Endocrinol., June 1, 2007; 193(3): 323 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Jerng, Y.-C. Hsu, H.-D. Wu, H.-Z. Pan, H.-C. Wang, C.-T. Shun, C.-J. Yu, and P.-C. Yang Role of the renin-angiotensin system in ventilator-induced lung injury: an in vivo study in a rat model Thorax, June 1, 2007; 62(6): 527 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Wilson, J. M. Napper, J. Denvir, V. E. Sollars, and H. D. Yu Defect in early lung defence against Pseudomonas aeruginosa in DBA/2 mice is associated with acute inflammatory lung injury and reduced bactericidal activity in naive macrophages Microbiology, April 1, 2007; 153(4): 968 - 979. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Rahman and I. M. Adcock Oxidative stress and redox regulation of lung inflammation in COPD. Eur. Respir. J., July 1, 2006; 28(1): 219 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Belvisi Regulation of Inflammatory Cell Function by Corticosteroids Proceedings of the ATS, November 1, 2004; 1(3): 207 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Kim, S. Y. Lee, S. M. Bak, I. B. Suh, S. Y. Lee, C. Shin, J. J. Shim, K. H. In, K. H. Kang, and S. H. Yoo Effects of matrix metalloproteinase inhibitor on LPS-induced goblet cell metaplasia Am J Physiol Lung Cell Mol Physiol, July 1, 2004; 287(1): L127 - L133. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Matsue, D. Edelbaum, D. Shalhevet, N. Mizumoto, C. Yang, M. E. Mummert, J. Oeda, H. Masayasu, and A. Takashima Generation and Function of Reactive Oxygen Species in Dendritic Cells During Antigen Presentation J. Immunol., September 15, 2003; 171(6): 3010 - 3018. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |